RAVALI TARIGOPULA M.D. NPI 1285802892

NPI Details

Ravali Tarigopula, M.D. is a pulmonary disease internal medicine in Monroe, LA with 21 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. Ravali Tarigopula, M.D. NPI is 1285802892. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

309 JACKSON ST
MONROE, LA
ZIP 71201-407
Phone: (318) 966-4541
Fax: (318) 966-4543

The NPI 1285802892 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to measure rate of airflow (HCPCS:94375)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth (HCPCS:G0408)
• Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth (HCPCS:G0407)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Sleep study in sleep lab (6 years or older) (HCPCS:95810)
• Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth (HCPCS:G0427)
• Sleep study in sleep lab with continuous airway pressure (6 years or older) (HCPCS:95811)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Biopsy of lung airway using an endoscope (HCPCS:31625)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Exam of lung airways using an endoscope (HCPCS:31623)
• Test to measure oxygen level in blood using ear or finger device multiple times (HCPCS:94761)
• Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth (HCPCS:G0508)

The enumeration date for this NPI number is 2/16/2008 and was last updated on 7/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.